Ocean Biomedical receives Nasdaq notice for late 10-Q filing; must file delinquent reports by Oct 14

Ocean Biomedical, Inc.

Received Nasdaq notice on Aug 19, 2024 for failure to file Q2 2024 Form 10-Q on time.
Must submit compliance plan by Sept 3, 2024; all delinquent reports due by Oct 14, 2024.
Delinquent reports include Q1 2024 10-Q, Q2 2024 10-Q, and 2023 10-K.
No immediate effect on listing, but further delays risk delisting.
Company states it intends to file as soon as practicable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.